{(R)-1-[6-[2,2-Bis-(4-hydroxy-phenyl)-ethylamino]-9-((1R,2S,3R,4S)-2,3-dihydroxy-4-propionylamino-cyclopentyl)-9H-purin-2-yl]-pyrrolidin-3-yl}-carbamic acid tert-butyl ester trifluoroacetate → N-((1S,2R,3S,4R)-4-{2-((R)-3-Amino-pyrrolidin-1-yl)-6-[2,2-bis-(4-hydroxy-phenyl)-ethylamino]-purin-9-yl}-2,3-dihydroxy-cyclopentyl)-propionamide
反応式
FC(F)(F)C(O)=O.C(OC(=O)[NH:14][C@@H:15]1[CH2:19][CH2:18][N:17]([C:20]2[N:28]=[C:27]3[C:23]([N:24]=[CH:25][N:26]3[C@@H:29]3[CH2:33][C@H:32]([NH:34][C:35](=[O:38])[CH2:36][CH3:37])[C@@H:31]([OH:39])[C@H:30]3[OH:40])=[C:22]([NH:41][CH2:42][CH:43]([C:51]3[CH:56]=[CH:55][C:54]([OH:57])=[CH:53][CH:52]=3)[C:44]3[CH:49]=[CH:48][C:47]([OH:50])=[CH:46][CH:45]=3)[N:21]=2)[CH2:16]1)(C)(C)C>C(Cl)Cl.C(O)(C(F)(F)F)=O>[NH2:14][C@@H:15]1[CH2:19][CH2:18][N:17]([C:20]2[N:28]=[C:27]3[C:23]([N:24]=[CH:25][N:26]3[C@@H:29]3[CH2:33][C@H:32]([NH:34][C:35](=[O:38])[CH2:36][CH3:37])[C@@H:31]([OH:39])[C@H:30]3[OH:40])=[C:22]([NH:41][CH2:42][CH:43]([C:44]3[CH:49]=[CH:48][C:47]([OH:50])=[CH:46][CH:45]=3)[C:51]3[CH:56]=[CH:55][C:54]([OH:57])=[CH:53][CH:52]=3)[N:21]=2)[CH2:16]1参加物
4
反応物 1
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of {(R)-1-[6-[2,2-Bis-(4-hydroxy-phenyl)-ethylamino]-9-((1R,2S,3R,4S)-2,3-dihydroxy-4-propionylamino-cyclopentyl)-9H-purin-2-yl]-pyrrolidin-3-yl}-carbamic acid tert-butyl ester trifluoroacetate (0.4 g, 0.57 mmol) in DCM (5 ml) and TFA (2.5 ml) is stirred at room temperature for 2 hours. The solvent is removed in vacuo to afford the title compound.
後処理
- customThe solvent is removed in vacuo
出典と根拠
- ORDレコード
- ord-fd1ded61ec65485591b2547fbcbcda3e
- 出典データセット
- uspto-grants-2012_11
- 特許番号
- US08318750B2
関連ノート
読み込み中…